Todd Harrison Discusses Biopharmaceutical Investments

Bloomberg Opinion columnist Barry Ritholtz interviews Todd
Harrison, a founding partner and chief investment officer at the
hedge fund CB1 Capital, which focuses on cannabinoid-based
solutions and biopharmaceutical applications and therapies. Prior
to his work with CB1 Capital, Harrison spent almost three decades
on Wall Street managing risk and researching financial market
strategies. He was also the


founder and CEO of Minyanville Media Inc., an Emmy-winning
financial media company covering global markets in real
time. 


See omnystudio.com/listener for privacy information.